Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Those on tirzepatide lowered their A1c by 2-2.3 percentage points (depending on injection dose) compared to those on semaglutide who achieved a reduction of 1.86 percentage points (with 1 mg weekly injections)
Vella A, Shah P, Basu R, Basu A, Holst JJ, Rizza RA
An employer's guide to GLP-1s for obesity | Kaiser Permanente You need to enable JavaScript to run this app.
4 Months 34.5 Peak Results & Habit Building Maximum therapeutic dose achieved
US$ 28.20
US$ 28.67
US$ 25.64
US$ 21.26
US$ 21.80
US$ 22.94
US$ 29.62
US$ 22.30
US$ 21.45
